www.barrons.com
Open in
urlscan Pro
2600:9000:2250:2a00:14:c68f:c40:93a1
Public Scan
URL:
https://www.barrons.com/articles/fda-drug-stocks-decisions-51647468511?mod=past_editions
Submission: On March 21 via api from CH — Scanned from DE
Submission: On March 21 via api from CH — Scanned from DE
Form analysis 1 forms found in the DOM
<form autocomplete="off">
<div id="scrim-from-wrap" class="input-wrap">
<label for="scrim-from">From</label>
<textarea id="scrim-from" readonly="readonly" disabled="disabled" type="text" autocomplete="off" autocorrect="off" autocapitalize="none"></textarea>
</div>
<div id="scrim-to-wrap" class="input-wrap">
<label for="scrim-to">To</label>
<input id="scrim-to" type="text" autocomplete="off" autocorrect="off" autocapitalize="none">
</div>
<div class="input-wrap">
<label for="scrim-message">Message</label>
<textarea id="scrim-message" class="msg" maxlength="500" type="text" autocomplete="off" autocorrect="off" autocapitalize="none"></textarea>
</div>
</form>Text Content
We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. CHROME SAFARI FIREFOX We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser.GoogleFirefox Search News & Quotes Barron's TopicsStock PicksMagazineDataAdvisorPenta100 Years Subscribe Now |Sign In Barrons The FDA Has a New Chief. Here Are 5 Key Decisions on Drugs to Watch. Next: Cyberattack Threats Are Increasing. This Stock Will Benefit. * * * * Share This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/fda-drug-stocks-decisions-51647468511 * Regulation * Feature THE FDA HAS A NEW CHIEF. HERE ARE 5 KEY DECISIONS ON DRUGS TO WATCH. * * * * -------------------------------------------------------------------------------- By Josh Nathan-Kazis Updated March 17, 2022 10:50 am ET / Original March 17, 2022 2:45 am ET * Order Reprints * Print Article llustration by Tim Boelaars The Food and Drug Administration’s new commissioner, Dr. Robert Califf, has arrived at his post at a moment of extraordinary scrutiny for the agency. Two years into the pandemic, the FDA is still facing pressing decisions about Covid-19 vaccines and treatments. That is in addition to high-stakes decisions about drug approvals. The lack of a permanent commissioner since President Joe Biden’s inauguration last year left investors guessing about the agency’s plans. Now, a series of decisions over the next few months could shed... Subscribe or Sign In to continue reading -------------------------------------------------------------------------------- * Technology * Streetwise CYBERATTACK THREATS ARE INCREASING. THIS STOCK WILL BENEFIT. * * * * -------------------------------------------------------------------------------- By Jack Hough Updated March 19, 2022 / Original March 18, 2022 * Order Reprints * Print Article As the Russian economy crumbles, state-linked hackers are likely to shift from ransomware crimes to attacks meant to maximize destruction and societal upheaval, the CEO of a top cybersecurity company tells me. Yes, that’s a bit like an umbrella salesman saying it’s getting cloudy. But in this case, the clouds really are dark gray rumblers, and more to the point for investors, umbrella sales are shooting higher. This was already happening, of course. The rise of cloud computing ballooned the number of devices linked to company... Subscribe or Sign In to continue reading -------------------------------------------------------------------------------- More from News Corp * Realtor.com Looking to buy your first home? You’ve come to the right place. * Wall Street Journal How ‘The Godfather,’ 50 Years On, Influences Generations of Showrunners * Mansion Global Record-Setting Buyer Strikes Again in Aspen With $44.5 Million Buy * The Hottest U.S. Real Estate Markets Just Hit a New Record-High Price—Prepare To Be Shocked * PENTA 400-Year-Old Iranian Carpet Once Owned by the Rothschild Family Heads to Auction Close THE FDA HAS A NEW CHIEF. HERE ARE 5 KEY DECISIONS ON DRUGS TO WATCH. The Food and Drug Administration’s new commissioner, Dr. From To Message SEND An error has occurred, please try again later. Thank you This article has been sent to Privacy Notice Cookie Notice Do Not Sell My Personal Information Copyright Policy Data Policy Your Ad Choices Subscriber Agreement & Terms of Use Barron's Archive Corporate Subscriptions Manage Notifications Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. Barron's Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.